Artgen Biotech PJSC (MOEX:ISKJ)
Russia
· Delayed Price · Currency is RUB 59.54
+0.84 (1.43%)
At close: Jul 8, 2022
Artgen Biotech PJSC Cash Flow Statement
Financials in millions RUB. Fiscal year is January - December.
Millions RUB. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 214.91 | 168.86 | 46.12 | 11.63 | 72.85 | Upgrade
|
| Depreciation & Amortization | 84.71 | 70.9 | 53.48 | 79.84 | 72.39 | Upgrade
|
| Other Amortization | - | - | - | 1.44 | 2.5 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.52 | 0.58 | 75.31 | 26.51 | -41.74 | Upgrade
|
| Loss (Gain) on Equity Investments | 3.5 | 24.17 | -23.14 | 5.21 | 0.37 | Upgrade
|
| Provision & Write-off of Bad Debts | 11.98 | 13.43 | 15.41 | 12.73 | 52.37 | Upgrade
|
| Other Operating Activities | 234.66 | 112.13 | 84.91 | 99.99 | 112.27 | Upgrade
|
| Change in Accounts Receivable | -28.52 | -92.46 | 86.7 | 8.72 | -118.1 | Upgrade
|
| Change in Inventory | -21.58 | -1.51 | 16.4 | -21.54 | -106.02 | Upgrade
|
| Change in Accounts Payable | -17.32 | 138.75 | -134.9 | 56.27 | 6.98 | Upgrade
|
| Operating Cash Flow | 481.83 | 434.85 | 220.3 | 280.8 | 53.86 | Upgrade
|
| Operating Cash Flow Growth | 10.80% | 97.39% | -21.55% | 421.32% | -70.58% | Upgrade
|
| Capital Expenditures | -99.68 | -204.29 | -135.93 | -153.3 | -85.6 | Upgrade
|
| Cash Acquisitions | -4.88 | - | -78.96 | - | -70.25 | Upgrade
|
| Investment in Securities | -0.17 | -46.86 | -66.1 | -71.49 | 84.76 | Upgrade
|
| Other Investing Activities | 52.55 | 27.04 | 5.48 | 6.12 | -2.57 | Upgrade
|
| Investing Cash Flow | -171.31 | -216.97 | -346.78 | -252.25 | -79.16 | Upgrade
|
| Long-Term Debt Issued | - | - | 196 | 319.23 | 145 | Upgrade
|
| Long-Term Debt Repaid | -122.78 | -83.76 | -14.19 | -194.64 | -92.46 | Upgrade
|
| Net Debt Issued (Repaid) | -122.78 | -83.76 | 181.81 | 124.59 | 52.54 | Upgrade
|
| Issuance of Common Stock | - | 38.89 | 43.8 | 3.49 | 4.02 | Upgrade
|
| Repurchase of Common Stock | -35.96 | - | - | - | - | Upgrade
|
| Other Financing Activities | -188 | 169.8 | -87.3 | -69.11 | -11.44 | Upgrade
|
| Financing Cash Flow | -346.74 | 124.94 | 138.31 | 58.96 | 45.12 | Upgrade
|
| Foreign Exchange Rate Adjustments | -5.38 | 0.46 | -3.46 | -1.61 | -2.18 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | 0 | - | - | Upgrade
|
| Net Cash Flow | -41.59 | 343.28 | 8.37 | 85.9 | 17.65 | Upgrade
|
| Free Cash Flow | 382.16 | 230.56 | 84.37 | 127.51 | -31.74 | Upgrade
|
| Free Cash Flow Growth | 65.75% | 173.26% | -33.83% | - | - | Upgrade
|
| Free Cash Flow Margin | 25.12% | 16.85% | 7.42% | 10.80% | -2.93% | Upgrade
|
| Free Cash Flow Per Share | 4.13 | 2.49 | 0.97 | 1.59 | -0.42 | Upgrade
|
| Cash Interest Paid | - | 52.1 | 48.6 | 50.71 | 27.15 | Upgrade
|
| Cash Income Tax Paid | - | 24.64 | 3.83 | 5.71 | - | Upgrade
|
| Levered Free Cash Flow | 123.67 | -27.31 | -133.41 | -12.27 | -21.61 | Upgrade
|
| Unlevered Free Cash Flow | 183.09 | 3.46 | -91.03 | 19.4 | 3.49 | Upgrade
|
| Change in Net Working Capital | -10.03 | 37.49 | 84.82 | 1.42 | 109.53 | Upgrade
|
Updated Sep 5, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.